Reina-Bautista E, Camacho-Moreno G, Arzate-Barbosa P, De Colsa-Ranero A

Language: Spanish
References: 10
Page: 369-372
PDF size: 294.50 Kb.

Text Extraction

No abstact.

REFERENCES

1. Butler KM. Enterococcal infection in children. Pediatri Infect Dis. 2006; 17: 128-139.

2. Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nature Rev. 2012; 10: 265-278.

3. Leal AL, Alvarez CA, Cortés JA, Ovalle MV. Análisis de la vigilancia de la resistencia bacteriana año 2011 componente pediátrico y adulto. Boletin informativo GREBO. 2012; 4: 11-15. Disponible en www.grebo.org

4. Cuellar-Rodríguez J, Galindo-Fraga A, Guevara V, Pérez- Jiménez C, Rolón AL, Hernández-Cruz A, et al. Vancomycin resistant Enterococci, Mexico City. Emerg Infect Dis. 2007; 13 (5): 798-799.

5. Leo-Amador GE, Borbolla-Ramos A, Morales-Lara JA, Pérez- González HA, Hernández-Montiel HL, Solis-S JC. Infection or colonization and antimicrobial susceptibilility of Enterococcus spp at a regional hospital in Queretaro, Mexico. Am J Infect Control. 2011; 39 (7): 615-616.

6. Amábile-Cuevas CF. Antibiotic resistance in Mexico: a brief overview of the current status and its causes. J Infect Dev Ctries. 2010; 4(3): 126-131.

7. Calderón-Jaimes E, Arredondo-García JL, Aguilar-Ituarte F, García-Roca P. In vitro antimicrobial susceptibility in clinical isolates of Enterococcus species. Salud Pública Mex. 2003; 45: 96-101.

8. Carmeli Y, Eliopoulos GM, Samore MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin- resistant Enterococcus. Emerg Infect Dis. 2002; 8(8): 802–7.

9. Cheen LF, Chopra T, Kaye KS. Pathogens resistant to antibacterial agents. Infect Dis Clin N Am. 2009; 23: 817–845.

10. Flamm RK, Farrel DJ, Mandez RE, Ross JE, Saders HS, Jones RN. LEADER Surveillance programs results for 2010: an activity and spectrum analysis of linezolid using 6801 clinical isolates form United States ( 61 medical centers). Diagn Microbiol Infect Dis. 2012; 74(1): 54-61.